Showing results (211-220 of 941) with videos related to
Sort By:
Pageof 95
Neurology and Therapy|April 26, 2024
Dental Adverse Effects of Anti-CD20 TherapiesHélène Bartak, Tasnim Fareh, Nouha Ben Othman, et al.Neurology and Therapy|April 8, 2024
Narrative Review on the Use of Cladribine Tablets as Exit Therapy for Stable Elderly Patients with Multiple SclerosisJerome de Seze, Dominique Dive, Xavier Ayrignac, et al.Neurology and Therapy|April 9, 2024
Methotrexate and the Risk of Dementia: A Two-Sample Mendelian Randomization StudyXiao-Na Ma, Wei Feng, Shu-Lin Chen, et al.Neurology and Therapy|October 19, 2023
Evaluating Perceived Fatigue within an Adult Spinal Muscular Atrophy PopulationLisa Belter, Ilse Peterson, Jill JareckiNeurology and Therapy|October 12, 2023
Cost-Effectiveness of Tonic Motor Activation (TOMAC) Therapy for Patients with Restless Legs Syndrome: An Exploratory AnalysisAnne M Ryschon, Khoa N Cao, Asim Roy, et al.Neurology and Therapy|April 2, 2026
Transcutaneous Auricular Vagal Nerve Stimulation Against Fatigue Syndrome in Patients with Long COVID: Results of the Randomized, Placebo-Controlled Clinical Pilot Trial COVIVAMortimer Gierthmuehlen, Kirsten Schmieder, Niklas Thon, et al.Neurology and Therapy|April 2, 2026
Exploring Preferences and Priorities in Advanced Parkinson's Disease: A Discrete Choice ExperimentPablo Arija, Josefa Domingos, Irene A Malaty, et al.Neurology and Therapy|May 22, 2026
Beyond B Cell Depletion: Adhesion and Activation Network Remodeling During Repeated Intravenous Anti-CD20 Therapy in Multiple SclerosisJulia Feige, Tobias Moser, Katja Akgün, et al.Neurology and Therapy|May 7, 2026
Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim ResultsWolfgang H Jost, Filip Bergquist, Andrew Evans, et al.Neurology and Therapy|June 9, 2026
Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III StudyPiero Barbanti, Cinzia Aurilia, Massimo Filippi, et al.Pageof 95